Art

J-GLOBAL ID：201602214334429242   Reference number：16A0103795

JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models

新規の腸特異的ミクロソームトリグリセリド輸送蛋白質阻害剤であるJTT-130は,高脂血症動物モデルの脂質代謝を改善し動脈硬化を緩和する

Author (8)： MERA Yasuko (Japan Tobacco Inc., Osaka, JPN) ,  KAWAI Takashi (Japan Tobacco Inc., Osaka, JPN) ,  OGAWA Naoto (Japan Tobacco Inc., Osaka, JPN) ,  ODANI Naoya (Japan Tobacco Inc., Osaka, JPN) ,  SASASE Tomohiko (Japan Tobacco Inc., Osaka, JPN) ,  MIYAJIMA Katsuhiro (Japan Tobacco Inc., Osaka, JPN) ,  OHTA Takeshi (Japan Tobacco Inc., Osaka, JPN) ,  KAKUTANI Makoto (Japan Tobacco Inc., Osaka, JPN)
Material： Journal of Pharmacological Sciences (Web)  (J Pharmacol Sci (Web))
Volume： 129  Issue： 3  Page： 169-176 (WEB ONLY)  Publication year： Nov. 2015 
JST Material Number： U0667A  ISSN： 1347-8613  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： Proteins ,...
Semi thesaurus term： lipid metabolic improvement action

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0103795&from=J-GLOBAL&jstjournalNo=U0667A") }}

JST classification (3)： Basic medicine on cardiovascular system  (GJ01020K) ,  Basic therapeutics  (GC03012A) ,  Basic research of drugs acting on lipid metabolism  (GW13040M)

Reference (32)：

• Merkler M, Reiner Z. The burden of hyperlipidaemia and diabetes in cardiovascular diseases. Fundam Clin Pharmacol. 2007;21(Suppl. 2):1-3.
• Graham I, Cooney MT, Bradley D, Dudina A, Reiner Z. Dyslipidemias in the prevention of cardiovascular disease: risks and causality. Curr Cardiol Rep. 2012;14:709-720.
• Matsumoto K, Kobayashi T, Kimura Y. Isolation and preliminary characterization of antigenic variant of echovirus type 11. J Med Virol. 1990;31: 253-258.
• Sahebkar A, Watts GF. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin Ther. 2013;35:1082-1098.
• Alla VM, Agrawal V, DeNazareth A, Mohiuddin S, Ravilla S, Rendell M. A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs. Drugs. 2013;73:1025-1054.

Terms in the title (9)： 腸 ,  ミクロソームトリグリセリド輸送蛋白質 ,  阻害剤 ,  高脂血症 ,  動物 ,  モデル ,  脂質代謝 ,  動脈硬化 ,  緩和